Among the 36 hub genes, only the five hub genes, namely, SYK, BIN2, ADAM12, CCR5, and MRC1, have a potential diagnostic value and are recognized as potential novel prognostic biomarkers in EM. This evidence concerns the gene BIN2 and erythema multiforme.